Alzamend Neuro (ALZN)
NASDAQ:ALZN
Holding ALZN?
Track your performance easily

Alzamend Neuro (ALZN) Financial Statements

235 Followers

Alzamend Neuro Financial Overview

Alzamend Neuro's market cap is currently ―. The company's EPS TTM is $-10.692; its P/E ratio is -0.16; Alzamend Neuro is scheduled to report earnings on March 16, 2023, and the estimated EPS forecast is $-6.00. See an overview of income statement, balance sheet, and cash flow financials.
Jul 24Apr 24Jan 24Oct 23Jul 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -962.40K$ -850.06K$ -2.66M$ -2.90M$ -3.53M
EBITDA$ -940.43K$ -836.66K$ -2.65M$ -2.89M$ -3.51M
Net Income Common Stockholders$ -974.41K$ -851.53K$ -2.66M$ -2.91M$ -3.53M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.19M$ 376.05K$ 282.87K$ 200.08K$ 1.70M
Total Assets$ 1.67M$ 631.59K$ 782.64K$ 983.60K$ 2.63M
Total Debt$ 0.00$ 300.71K$ 0.00$ 0.00$ 0.00
Net Debt$ -1.19M$ -75.33K$ -282.87K$ -200.08K$ -1.70M
Total Liabilities$ 2.88M$ 3.23M$ 4.57M$ 3.67M$ 2.74M
Stockholders Equity$ -1.21M$ -2.59M$ -4.26M$ -2.68M$ -112.88K
Cash Flow-
Free Cash Flow$ -1.15M$ -1.43M$ -2.03M$ -1.51M$ -3.45M
Operating Cash Flow$ -1.06M$ -1.43M$ -2.03M$ -1.51M$ -3.30M
Investing Cash Flow$ -90.00K---$ -147.24K
Financing Cash Flow$ 1.96M$ 1.52M$ 2.11M$ 18.09K-
Currency in USD

Alzamend Neuro Earnings and Revenue History

Alzamend Neuro Debt to Assets

Alzamend Neuro Cash Flow

Alzamend Neuro Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis